BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24847765)

  • 1. From inception to output, Tcf1 and Lef1 safeguard development of T cells and innate immune cells.
    Steinke FC; Xue HH
    Immunol Res; 2014 Aug; 59(1-3):45-55. PubMed ID: 24847765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T
    Li F; Zhao X; Zhang Y; Shao P; Ma X; Paradee WJ; Liu C; Wang J; Xue HH
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33372138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tcf1 and Lef1 transcription factors establish CD8(+) T cell identity through intrinsic HDAC activity.
    Xing S; Li F; Zeng Z; Zhao Y; Yu S; Shan Q; Li Y; Phillips FC; Maina PK; Qi HH; Liu C; Zhu J; Pope RM; Musselman CA; Zeng C; Peng W; Xue HH
    Nat Immunol; 2016 Jun; 17(6):695-703. PubMed ID: 27111144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-autonomous requirement for TCF1 and LEF1 in the development of Natural Killer T cells.
    Berga-Bolaños R; Zhu WS; Steinke FC; Xue HH; Sen JM
    Mol Immunol; 2015 Dec; 68(2 Pt B):484-9. PubMed ID: 26490636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells.
    Xing S; Gai K; Li X; Shao P; Zeng Z; Zhao X; Zhao X; Chen X; Paradee WJ; Meyerholz DK; Peng W; Xue HH
    J Exp Med; 2019 Apr; 216(4):847-866. PubMed ID: 30837262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nuclear effector of Wnt-signaling, Tcf1, functions as a T-cell-specific tumor suppressor for development of lymphomas.
    Tiemessen MM; Baert MR; Schonewille T; Brugman MH; Famili F; Salvatori DC; Meijerink JP; Ozbek U; Clevers H; van Dongen JJ; Staal FJ
    PLoS Biol; 2012; 10(11):e1001430. PubMed ID: 23185135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tcf1 and Lef1 provide constant supervision to mature CD8
    Shan Q; Li X; Chen X; Zeng Z; Zhu S; Gai K; Peng W; Xue HH
    Nat Commun; 2021 Oct; 12(1):5863. PubMed ID: 34615872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors.
    Grumolato L; Liu G; Haremaki T; Mungamuri SK; Mong P; Akiri G; Lopez-Bergami P; Arita A; Anouar Y; Mlodzik M; Ronai ZA; Brody J; Weinstein DC; Aaronson SA
    PLoS Genet; 2013; 9(8):e1003603. PubMed ID: 23966864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCF1 and LEF1 Control Treg Competitive Survival and Tfr Development to Prevent Autoimmune Diseases.
    Yang BH; Wang K; Wan S; Liang Y; Yuan X; Dong Y; Cho S; Xu W; Jepsen K; Feng GS; Lu LF; Xue HH; Fu W
    Cell Rep; 2019 Jun; 27(12):3629-3645.e6. PubMed ID: 31216480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors.
    Yu S; Li F; Xing S; Zhao T; Peng W; Xue HH
    J Biol Chem; 2016 May; 291(21):11148-60. PubMed ID: 27044748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell factor-1 and β-catenin control the development of memory-like CD8 thymocytes.
    Sharma A; Chen Q; Nguyen T; Yu Q; Sen JM
    J Immunol; 2012 Apr; 188(8):3859-68. PubMed ID: 22492686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Requirements for Tcf1 Long Isoforms in CD8
    Gullicksrud JA; Li F; Xing S; Zeng Z; Peng W; Badovinac VP; Harty JT; Xue HH
    J Immunol; 2017 Aug; 199(3):911-919. PubMed ID: 28652395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCF1 in T cell immunity: a broadened frontier.
    Zhao X; Shan Q; Xue HH
    Nat Rev Immunol; 2022 Mar; 22(3):147-157. PubMed ID: 34127847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting Edge: β-Catenin-Interacting Tcf1 Isoforms Are Essential for Thymocyte Survival but Dispensable for Thymic Maturation Transitions.
    Xu Z; Xing S; Shan Q; Gullicksrud JA; Bair TB; Du Y; Liu C; Xue HH
    J Immunol; 2017 May; 198(9):3404-3409. PubMed ID: 28348272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCF1 and beta-catenin regulate T cell development and function.
    Yu Q; Sharma A; Sen JM
    Immunol Res; 2010 Jul; 47(1-3):45-55. PubMed ID: 20082155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.
    Grueter B; Petter M; Egawa T; Laule-Kilian K; Aldrian CJ; Wuerch A; Ludwig Y; Fukuyama H; Wardemann H; Waldschuetz R; Möröy T; Taniuchi I; Steimle V; Littman DR; Ehlers M
    J Immunol; 2005 Aug; 175(3):1694-705. PubMed ID: 16034110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy.
    Yu S; Zhou X; Steinke FC; Liu C; Chen SC; Zagorodna O; Jing X; Yokota Y; Meyerholz DK; Mullighan CG; Knudson CM; Zhao DM; Xue HH
    Immunity; 2012 Nov; 37(5):813-26. PubMed ID: 23103132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microtubule actin crosslinking factor 1 promotes osteoblast differentiation by promoting β-catenin/TCF1/Runx2 signaling axis.
    Hu L; Su P; Yin C; Zhang Y; Li R; Yan K; Chen Z; Li D; Zhang G; Wang L; Miao Z; Qian A; Xian CJ
    J Cell Physiol; 2018 Feb; 233(2):1574-1584. PubMed ID: 28621459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCF-1 and LEF-1 act upstream of Th-POK to promote the CD4(+) T cell fate and interact with Runx3 to silence Cd4 in CD8(+) T cells.
    Steinke FC; Yu S; Zhou X; He B; Yang W; Zhou B; Kawamoto H; Zhu J; Tan K; Xue HH
    Nat Immunol; 2014 Jul; 15(7):646-656. PubMed ID: 24836425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD1 is transcriptionally regulated by LEF1 in mature T cells.
    Zhao P; Sun L; Zhao C; Malik S
    Immunobiology; 2023 Sep; 228(5):152708. PubMed ID: 37523793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.